Sign inGet started

Lim Richard J.

Insider CIK 1623720 · PRTK Director · KZR · MORF 10% owner · TBIO 10% owner · REPL 10% owner

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
MORF Morphic Holding, Inc. C Conversion deriv2019-07-012019-07-01857,470— $00SEC↗
MORF Morphic Holding, Inc. C Conversion deriv2019-07-012019-07-011,978,779— $00SEC↗
MORF Morphic Holding, Inc. C Conversion2019-07-012019-07-01857,470— $0857,470SEC↗
MORF Morphic Holding, Inc. P Buy2019-07-012019-07-01133,333$15.00 $2.00M2,969,582SEC↗
MORF Morphic Holding, Inc. C Conversion2019-07-012019-07-011,978,779— $02,836,249SEC↗
REPL Replimune Group, Inc. A Award deriv2019-04-012019-04-0313,500— $013,500SEC↗
REPL Replimune Group, Inc. C Conversion deriv2018-07-242018-07-2525,000— $00SEC↗
REPL Replimune Group, Inc. C Conversion deriv2018-07-242018-07-25101,896— $00SEC↗
REPL Replimune Group, Inc. C Conversion deriv2018-07-242018-07-25259,366— $00SEC↗
REPL Replimune Group, Inc. C Conversion deriv2018-07-242018-07-25100,000— $00SEC↗
REPL Replimune Group, Inc. C Conversion deriv2018-07-242018-07-25248,672— $0248,672SEC↗
REPL Replimune Group, Inc. P Buy2018-07-242018-07-25266,667$15.00 $4.00M266,667SEC↗
REPL Replimune Group, Inc. C Conversion2018-07-242018-07-251,013,547— $04,854,783SEC↗
REPL Replimune Group, Inc. C Conversion2018-07-242018-07-25994,688— $01,261,355SEC↗
REPL Replimune Group, Inc. C Conversion2018-07-242018-07-252,579,881— $03,841,236SEC↗
REPL Replimune Group, Inc. A Award deriv2018-07-192018-07-2513,500— $013,500SEC↗
TBIO Translate Bio, Inc. C Conversion deriv2018-07-022018-07-032,500,000— $00SEC↗
TBIO Translate Bio, Inc. C Conversion deriv2018-07-022018-07-032,500,000— $00SEC↗
TBIO Translate Bio, Inc. C Conversion deriv2018-07-022018-07-031,676,348— $00SEC↗
TBIO Translate Bio, Inc. C Conversion deriv2018-07-022018-07-031,676,348— $00SEC↗
TBIO Translate Bio, Inc. C Conversion deriv2018-07-022018-07-031,263,484— $00SEC↗
TBIO Translate Bio, Inc. C Conversion deriv2018-07-022018-07-031,263,484— $00SEC↗
TBIO Translate Bio, Inc. C Conversion deriv2018-07-022018-07-03302,173— $00SEC↗
TBIO Translate Bio, Inc. C Conversion deriv2018-07-022018-07-03302,173— $00SEC↗
TBIO Translate Bio, Inc. C Conversion deriv2018-07-022018-07-032,000,103— $00SEC↗
TBIO Translate Bio, Inc. C Conversion deriv2018-07-022018-07-032,000,103— $00SEC↗
TBIO Translate Bio, Inc. C Conversion deriv2018-07-022018-07-035,800,000— $00SEC↗
TBIO Translate Bio, Inc. C Conversion deriv2018-07-022018-07-035,800,000— $00SEC↗
TBIO Translate Bio, Inc. C Conversion2018-07-022018-07-03979,179— $0979,179SEC↗
TBIO Translate Bio, Inc. C Conversion2018-07-022018-07-03979,179— $0979,179SEC↗
TBIO Translate Bio, Inc. C Conversion2018-07-022018-07-031,458,424— $01,458,424SEC↗
TBIO Translate Bio, Inc. C Conversion2018-07-022018-07-031,458,424— $01,458,424SEC↗
KZR Kezar Life Sciences, Inc. C Conversion deriv2018-06-252018-06-25377,783— $00SEC↗
KZR Kezar Life Sciences, Inc. C Conversion deriv2018-06-252018-06-25377,783— $00SEC↗
KZR Kezar Life Sciences, Inc. C Conversion deriv2018-06-252018-06-25315,489— $00SEC↗
KZR Kezar Life Sciences, Inc. C Conversion deriv2018-06-252018-06-25315,489— $00SEC↗
KZR Kezar Life Sciences, Inc. C Conversion2018-06-252018-06-25377,783— $0693,272SEC↗
KZR Kezar Life Sciences, Inc. C Conversion2018-06-252018-06-25377,783— $0693,272SEC↗
KZR Kezar Life Sciences, Inc. C Conversion2018-06-252018-06-25315,489— $0315,489SEC↗
KZR Kezar Life Sciences, Inc. C Conversion2018-06-252018-06-25315,489— $0315,489SEC↗
PRTK Paratek Pharmaceuticals, I P Buy2016-06-272016-06-29384,615$13.00 $5.00M779,802SEC↗
PRTK Paratek Pharmaceuticals, I P Buy2016-06-272016-06-2976,923$13.00 $1000.0K1,187,365SEC↗
PRTK Paratek Pharmaceuticals, I J Other deriv2014-10-302014-11-032,329— $02,329SEC↗
PRTK Paratek Pharmaceuticals, I J Other deriv2014-10-302014-11-034,083— $04,083SEC↗
PRTK Paratek Pharmaceuticals, I J Other2014-10-302014-11-03395,187— $0395,187SEC↗
PRTK Paratek Pharmaceuticals, I J Other2014-10-302014-11-03633,243— $0633,243SEC↗
PRTK Paratek Pharmaceuticals, I J Other2014-10-302014-11-031,110,442— $01,110,442SEC↗